Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Tuberculosis

Free Subscription Articles published in Eur J Clin Microbiol Infect Dis Retrieve available abstracts of 21 articles: HTML format Text format

Single Articles

August 2019
1. GARCIA-RODRIGUEZ JF, Valcarce-Pardeiro N, Alvarez-Diaz H, Marino-Callejo A, et al
   Long-term efficacy of 6-month therapy with isoniazid and rifampin compared with isoniazid, rifampin, and pyrazinamide treatment for pleural tuberculosis.
   Eur J Clin Microbiol Infect Dis. 2019 Aug 3. pii: 10.1007/s10096-019-03651.
   PubMed     Text format     Abstract available
   
   
   July 2019
2. DU J, Shu W, Liu Y, Wang Y, et al
   Development and validation of external quality assessment panels for mycobacterial culture testing to diagnose tuberculosis in China.
   Eur J Clin Microbiol Infect Dis. 2019 Jul 24. pii: 10.1007/s10096-019-03634.
   PubMed     Text format     Abstract available
   
   
   April 2019
3. WEN S, Jing W, Zhang T, Zong Z, et al
   Comparison of in vitro activity of the nitroimidazoles delamanid and pretomanid against multidrug-resistant and extensively drug-resistant tuberculosis.
   Eur J Clin Microbiol Infect Dis. 2019 Apr 5. pii: 10.1007/s10096-019-03551.
   PubMed     Text format     Abstract available
   
   
   February 2019
4. MA Y, Che NY, Liu YH, Shu W, et al
   The joint impact of smoking plus alcohol drinking on treatment of pulmonary tuberculosis.
   Eur J Clin Microbiol Infect Dis. 2019 Feb 15. pii: 10.1007/s10096-019-03489.
   PubMed     Text format     Abstract available
   
   
   January 2019
5. HODILLE E, Maisson A, Charlet L, Bauduin C, et al
   Evaluation of Xpert MTB/RIF Ultra performance for pulmonary tuberculosis diagnosis on smear-negative respiratory samples in a French centre.
   Eur J Clin Microbiol Infect Dis. 2019 Jan 24. pii: 10.1007/s10096-018-03463.
   PubMed     Text format     Abstract available
   
   
   July 2018
6. CENCI E, Luciano E, Bucaioni M, Rubeca M, et al
   Evaluation of IVD 3.0 Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of Mycobacterium tuberculosis and nontuberculous mycobacteria and its use in routine diagnostics.
   Eur J Clin Microbiol Infect Dis. 2018 Jul 14. pii: 10.1007/s10096-018-3326.
   PubMed     Text format    
   
   
   May 2018
7. ORIKIRIZA P, Nansumba M, Nyehangane D, Bastard M, et al
   Xpert MTB/RIF diagnosis of childhood tuberculosis from sputum and stool samples in a high TB-HIV-prevalent setting.
   Eur J Clin Microbiol Infect Dis. 2018 May 8. pii: 10.1007/s10096-018-3272.
   PubMed     Text format     Abstract available
   
   
   April 2018
8. MA Y, Pang Y, Shu W, Liu YH, et al
   Metformin reduces the relapse rate of tuberculosis patients with diabetes mellitus: experiences from 3-year follow-up.
   Eur J Clin Microbiol Infect Dis. 2018 Apr 20. pii: 10.1007/s10096-018-3242.
   PubMed     Text format     Abstract available
   
   
   
9. BRODA A, Nikolayevskyy V, Casali N, Khan H, et al
   Experimental platform utilising melting curve technology for detection of mutations in Mycobacterium tuberculosis isolates.
   Eur J Clin Microbiol Infect Dis. 2018 Apr 20. pii: 10.1007/s10096-018-3246.
   PubMed     Text format     Abstract available
   
   
   
10. SEKI M, Kim CK, Hayakawa S, Mitarai S, et al
    Recent advances in tuberculosis diagnostics in resource-limited settings.
    Eur J Clin Microbiol Infect Dis. 2018 Apr 19. pii: 10.1007/s10096-018-3258.
    PubMed     Text format     Abstract available
    
    
    
11. DE GEYTER D, Cnudde D, Van der Beken M, Autaers D, et al
    Evaluation of the Copan Myco-TB kit for the decontamination of respiratory samples for the detection of Mycobacteria.
    Eur J Clin Microbiol Infect Dis. 2018;37:711-714.
    PubMed     Text format     Abstract available
    
    
    November 2017
12. LACHMANDAS E, Thiem K, van den Heuvel C, Hijmans A, et al
    Patients with type 1 diabetes mellitus have impaired IL-1beta production in response to Mycobacterium tuberculosis.
    Eur J Clin Microbiol Infect Dis. 2017 Nov 30. pii: 10.1007/s10096-017-3145.
    PubMed     Text format     Abstract available
    
    
    August 2017
13. LIN HC, Perng CL, Lai YW, Lin FG, et al
    Molecular screening of multidrug-resistance tuberculosis by a designated public health laboratory in Taiwan.
    Eur J Clin Microbiol Infect Dis. 2017 Aug 24. doi: 10.1007/s10096-017-3082.
    PubMed     Text format     Abstract available
    
    
    
14. NASIRI MJ, Zamani S, Pormohammad A, Feizabadi MM, et al
    The reliability of rifampicin resistance as a proxy for multidrug-resistant tuberculosis: a systematic review of studies from Iran.
    Eur J Clin Microbiol Infect Dis. 2017 Aug 19. doi: 10.1007/s10096-017-3079.
    PubMed     Text format     Abstract available
    
    
    July 2017
15. NAMBIAR R, Chatellier S, Bereksi N, van Belkum A, et al
    Evaluation of Mycotube, a modified version of Lowenstein-Jensen (LJ) medium, for efficient recovery of Mycobacterium tuberculosis (MTB).
    Eur J Clin Microbiol Infect Dis. 2017 Jul 6. doi: 10.1007/s10096-017-3052.
    PubMed     Text format     Abstract available
    
    
    June 2017
16. HONG MS, Kim Y, Cho EJ, Lee JS, et al
    Comparison of the characteristics of Mycobacterium tuberculosis isolates from sputum and lung lesions in chronic tuberculosis patients.
    Eur J Clin Microbiol Infect Dis. 2017 Jun 15. doi: 10.1007/s10096-017-3025.
    PubMed     Text format     Abstract available
    
    
    
17. MNYAMBWA NP, Kim DJ, Ngadaya ES, Kazwala R, et al
    Clinical implication of novel drug resistance-conferring mutations in resistant tuberculosis.
    Eur J Clin Microbiol Infect Dis. 2017 Jun 7. doi: 10.1007/s10096-017-3027.
    PubMed     Text format     Abstract available
    
    
    April 2017
18. WEN HL, Li CL, Li G, Lu YH, et al
    Involvement of methylated HBHA expressed from Mycobacterium smegmatis in an IFN-gamma release assay to aid discrimination between latent infection and active tuberculosis in BCG-vaccinated populations.
    Eur J Clin Microbiol Infect Dis. 2017 Apr 20. doi: 10.1007/s10096-017-2948.
    PubMed     Text format     Abstract available
    
    
    December 2016
19. TAN Y, Su B, Zheng H, Wang Y, et al
    Prothionamide susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTECMGIT 960 system.
    Eur J Clin Microbiol Infect Dis. 2016 Dec 20. doi: 10.1007/s10096-016-2859.
    PubMed     Text format     Abstract available
    
    
    September 2016
20. KULLIN B, Wojno J, Abratt V, Reid SJ, et al
    Toxin A-negative toxin B-positive ribotype 017 Clostridium difficile is the dominant strain type in patients with diarrhoea attending tuberculosis hospitals in Cape Town, South Africa.
    Eur J Clin Microbiol Infect Dis. 2016.
    PubMed     Text format     Abstract available
    
    
    April 2016
21. SINGH VK, Srivastava R, Srivastava BS
    Manipulation of BCG vaccine: a double-edged sword.
    Eur J Clin Microbiol Infect Dis. 2016;35:535-43.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: